Zdrowie i gospodarka · 12/04/2011
FDA Clears Path for Cephalexin Capsule Approval
The FDA has determined that KEFLEX (cephalexin) capsule, equivalent to 333 milligrams base, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Source: Federal Register — Health and Human ServicesOpen original release →